Jeremy Force

Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor

A. Norden-Zfoni, Jayesh Desai, Judith Manola et al. · Clinical Cancer Research · 2007 · 198 citations

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)

Oluwadamilola M. Fayanju, Yi Ren, Samantha M. Thomas et al. · Annals of Surgery · 2018 · 196 citations

Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity

Paul Beaudry, Jeremy Force, George N. Naumov et al. · Clinical Cancer Research · 2005 · 158 citations · Full text

Therapeutic Efficacy of Endostatin Exhibits a Biphasic Dose-Response Curve

Ilhan Celik, Oǧuzkan Sürücü, Carsten Dietz et al. · Cancer Research · 2005 · 129 citations

Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells.

Gunter Schuch, John V. Heymach, Masashi Nomi et al. · PubMed · 2003 · 112 citations

Endothelial Cells, Immunology, Cellular Physiology +17